I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| intestinal crypt stem cell | 5 studies | 40% ± 13% | |
| transit amplifying cell | 5 studies | 31% ± 6% | |
| pro-B cell | 5 studies | 32% ± 14% | |
| CD8-positive, alpha-beta T cell | 5 studies | 25% ± 6% | |
| B cell | 4 studies | 36% ± 10% | |
| hematopoietic precursor cell | 4 studies | 38% ± 8% | |
| epithelial cell | 4 studies | 30% ± 6% | |
| CD4-positive, alpha-beta T cell | 4 studies | 23% ± 2% | |
| germinal center B cell | 3 studies | 25% ± 6% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 45% ± 19% | |
| precursor B cell | 3 studies | 42% ± 11% | |
| T cell | 3 studies | 25% ± 6% |
